Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Bassem Hassan joins Paris Brain Institute

Published on: 29/01/2016 Reading time: 1 min
bassem hassan
Retour à la recherche

Paris Brain Institute brings together in one place patients, doctors and researchers in order to rapidly develop treatments for nerve damage and apply these to patients as soon as possible. Coming from all backgrounds and countries, the best scientists work on the most advanced research in the field. In 2013, an international call for tender was launched to welcome new teams. In this context, Bassem Hassan, a world-renowned neuroscientist, joined the Institut du Cerveau - ICM alongside the 25 existing research teams.

BASSEM HASSAN, SCIENTIFIC EXCELLENCE FOR PATIENT CARE

The Bassem Hassan team focuses on the genetic mechanisms that control early development of the nervous system, cell specification in the formation of neural circuits, as well as the mechanisms involved in neurological diseases, by using Drosophila as a model.

Bassem Hassan team focuses on three main areas of study:

  • The relationship between the individual specificity of a brain network and his/her behaviour
  • The molecular mechanisms responsible for the differentiation of neural stem cells
  • The study of the mechanisms in some diseases:
    • Alzheimer’s disease, by investigating whether the modulation of Wnt signaling pathway by the precursor of amyloid peptide plays a role in the pathology
    • The fragile-X syndrome, studying whether the fragile-X protein plays a role in brain organisation

ABOUT BASSEM HASSAN

Bassem Hassan joined Paris Brain Institute in January 2016 where he is now head of the “Brain Development” team. Once obtained his PhD in molecular genetics at Ohio University in 1996, he completed his post-doctorate at Baylor College of Medicine in Houston, Texas. From 2001 to 2015, he was senior group leader at “VIB Center for the Biology of Disease” and Professor at the “Center for Human Genetics” at the University of Leuven in Belgium. In 2003, he was awarded the EMBO “Young Investigator” and in 2009 he was elected EMBO member. In 2015, he was named “Einstein Visiting Fellow” for 2016-2018 years at the Free University of Berlin and NeuroCure cluster.

A CALL FOR TENDERS REVEALING THE STRONG ATTRACTIVENESS OF THE Institut du Cerveau - ICM

A call for tenders was launched in spring 2013 to welcome new teams. The Institute received 83 application forms, 90% of international candidates. The interviews were conducted in February 2014. 11 shortlisted candidates were heard by the International Scientific Council of the Institute. A final selection was made late 2014 / early 2015.

Bassem Hassan was ranked first within the international “new teams” call.

With his work, Bassem Hassan, alongside 650 researchers, engineers and technicians of the Institute, will contribute to major progress for nervous system diseases.

Our news on the subject

L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
See all our news